Day: February 1, 2024

HII Reports Fourth Quarter and Full Year 2023 Results

Written by Customer Service on February 1, 2024. Posted in Earnings Releases And Operating Results.

Fourth quarter revenues grew 13% year over year, to a record $3.2 billion Record 2023 revenues of $11.5 billion, grew 7.3% year over year Diluted earnings per share was $6.90 for the fourth quarter, $17.07 for 2023 Net cash provided from operations was $970 million, and free cash flow1 was $692 million in 2023NEWPORT NEWS, Va., Feb. 01, 2024 (GLOBE NEWSWIRE) — HII (NYSE:HII) reported fourth quarter 2023 revenues of $3.2 billion, up 13% from the fourth quarter of 2022, due to higher volumes at all three segments. Operating income in the fourth quarter of 2023 was $312 million and operating margin was 9.8%, compared to $105 million and 3.7%, respectively, in the fourth quarter of 2022, primarily due to higher segment operating income1. Diluted earnings per share in the quarter was $6.90, compared to $3.07 in the fourth quarter...

Form 8.3 – [YOUNG & CO.’S BREWERY PLC 31 01 2024] – (CGWL)

Written by Customer Service on February 1, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree YOUNG & CO.’S BREWERY PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Allegro MicroSystems Reports Third Quarter 2024 Results

Written by Customer Service on February 1, 2024. Posted in Public Companies.

–Total Sales Increased 2% Year-over-Year ––E-Mobility Drives 18% Year-over-Year Increase in Automotive Sales – MANCHESTER, N.H., Feb. 01, 2024 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq:ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its third quarter ended December 29, 2023. “We delivered third-quarter net sales of $255 million, up 2% year-over-year, driven by continued strength in Automotive, which grew 18% year-over-year. Non-GAAP EPS was $0.32, 10% above the midpoint of guidance on in-line sales, and free cash flow increased $27 million, or more than 170% sequentially,” said Vineet Nargolwala, President and CEO of Allegro. “Sales into e-Mobility applications increased by 45%...

Lithium Ionic Appoints Mike Westendorf as Vice President of Technical Services, Further Enhancing its Operational Team as it Advances Bandeira, Minas Gerais, Brazil

Written by Customer Service on February 1, 2024. Posted in Public Companies.

TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is pleased to announce the appointment of Mike Westendorf to the position of Vice President of Technical Services, effective immediately. Mr. Westendorf is a professional engineer with over 15 years of diversified experience in mining operations, capital projects, engineering, and corporate development. Blake Hylands, P.Geo., Chief Executive Officer of Lithium Ionic, commented: “We are thrilled to welcome Mike to the Lithium Ionic team. His demonstrated track record in all aspects of the mine lifecycle, from study to production, will be invaluable as we quickly advance the Bandeira lithium project towards a production decision. Mike’s technical expertise and proven leadership abilities...

Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference

Written by Customer Service on February 1, 2024. Posted in Public Companies.

PITTSBURGH, Feb. 01, 2024 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim 6th Annual Biotechnology Conference, which takes place in New York on February 7-8. Krish S. Krishnan, Chairman and Chief Executive Officer, will participate in a fireside chat at 10 am ET during the conference and host investor meetings on February 7. A webcast of the presentation will be available here beginning at 10 am ET on Wednesday, February 7 and will be posted on the Investors section of the Company’s website. About Krystal Biotech, Inc.Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases...

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Written by Customer Service on February 1, 2024. Posted in Public Companies.

PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Tuesday, February 8th, 2024 at 2:30 PM ET. A replay of the event will be available on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations and will be available for 90 days following the event. About Century Therapeutics Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy...

Stella-Jones Will Hold a Conference Call to Discuss Its Fourth-Quarter Results

Written by Customer Service on February 1, 2024. Posted in Public Companies.

MONTREAL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX:SJ). OPEN TO: Investors, analysts and all interested parties DATE: Thursday, February 29, 2024 TIME: 10:00 AM Eastern Standard Time LIVE WEBCAST: https://web.lumiagm.com/440096911 CALL: 1-866-518-4114 THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE CALL THROUGH GLOBENEWSWIRE. Please log on or dial in 15 minutes before the conference begins. If you are unable to attend at this time, you may access a web recording of the meeting at the following link: https://web.lumiagm.com/440096911. This recording will be available on Thursday, February 29, 2024 as of 1:00 PM EST until 11:59 PM EST on Thursday March 7, 2024. MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR...

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Written by Customer Service on February 1, 2024. Posted in Public Companies.

CHARLOTTESVILLE, Va., Feb. 01, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today the appointment of James Doherty, Ph.D., as President and Chief Development Officer, effective February 1, 2024, reporting to Daniel O’Connell, Chief Executive Officer. Dr. Doherty’s responsibilities will include oversight of clinical and non-clinical development, chemistry, manufacturing & controls and regulatory functions. “We are extremely excited to welcome Jim, who brings extensive experience and demonstrated leadership abilities in CNS drug development to Acumen,” Mr. O’Connell said. “I look forward to collaborating with him as we prepare to...

Lantronix to Report Fiscal 2024 Second Quarter Results on Feb. 8, 2024

Written by Customer Service on February 1, 2024. Posted in Public Companies.

IRVINE, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (the “Company”) (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions that target high-growth industries in Smart Cities, Automotive and Enterprise, today announced it will release financial results from its fiscal 2024 second quarter ended Dec. 31, 2023, after the close of the market on Feb. 8, 2024. Management will host an investor conference call and audio webcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Feb. 8, 2024. To access the live conference call, investors should dial 1-844-802-2442 (US) or 1-412-317-5135 (international) and indicate that they are participating in the Lantronix fiscal 2024 second-quarter call. The webcast will be available simultaneously via the investor relations section of the Company’s website. Investors...

Applied UV, Inc. to Develop Smart Building Technologies for Larimar City, a New Luxury Development With Six Hotels and 20,000 High-end Residences – Potential Revenues Could Total $250 Million to $300 Million

Written by Customer Service on February 1, 2024. Posted in Public Companies.

Applied UV, Inc.A Rendering of Larimar City & Resort in the Dominican RepublicMax Munn, CEO of AUVI, states: “We estimate that potential revenues from this project could total $250 Million to $300 Million over the next 3 to 6 years.” AUVI subsidiaries (MunnWorks, SteriLumen & LED), in talks with the developer to supply UV disinfection, energy saving smart building control solutions and custom interiors. NEW YORK, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Applied UV, Inc. (“Applied UV” or the “Company”) (Nasdaq: AUVI), a leader in smart building technology solutions, announced plans to develop case goods and smart building technologies for Larimar City & Resort, a new multi-use development under construction in the Dominican Republic. The Company expects to deliver prototype case goods, and...

Day: February 1, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals